Knowledge, Attitude, and Practice Towards COVID-19 Among General Population of Karachi South: A Cross-Sectional Survey
DOI:
https://doi.org/10.36570/jduhs.2020.2.991Keywords:
COVID-19, knowledge, awareness, precautions, protectionAbstract
Objective: To assess the knowledge, attitude, and practices of precautionary measures against COVID-19 by the general population of Karachi South, Pakistan.
Methods: This descriptive cross-sectional questionnaire-based survey was conducted among the general population living in the district South of Karachi, Pakistan from April to May 2020. A structured questionnaire was formed using google forms, containing 31 questions regarding knowledge regarding transmission, signs and symptoms of the coronavirus, attitude, and precautionary measures for novel coronavirus outbreak were noted.
Results: Of 400 participants, most of the participants 259 (64.8%) were from 20-30 years of age group with females predominantly higher, i.e. 217 (54.3%). The majority of the participants 315 (78.5%) believed that COVID-19 is a viral infection. The majority of the participants 328 (82.0%) believed that COVID-19 starts with flu-like symptoms whereas few of them 65 (16.3%) thought stomach upset was also part of it. Similarly, majority of the participants, 320 (80.0%) presumed that elderly population was most effected by COVID-19 pandemic. The majority 286 (71.5%) of the participants were consuming home-based food rich in vitamin c and zinc. only 233 (58.3%) participants preferred to wear a surgical mask. Regarding use of supplements to boost immunity, 213 (53.3%) of the participants were not taking supplements, comparatively 186 (46.5%) consumed it.
Conclusion: Currently COVID-19 outbreak is on rise worldwide, but the general population is cognizant of knowledge, attitude, and practices of precautionary measures against it. Our findings can be useful for public health authorities, clinicians, and media to intercept the transmission of COVID-19.
Downloads
References
doi: 10.1056/NEJMoa2001316
2. Minskaia E, Hertzig T, Alexander E, Gorbalenya AE, Cambillau C, Canard B, et al. Discovery of an RNA virus exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc Natl Acad Sci. 2006; 103:5108-113.
doi: 10.1073/pnas.0508200103
3. Algaissi A, Agrawal AS, Hashem AM, Tseng TC. Quantification of the Middle East Respiratory Syndrome-Coronavirus RNA in Tissues by Quantitative Real-Time RT-PCR. MERS Coronavirus. 2020; 2099: 99-106. doi: 10.1007/978-1-0716-0211-9_8
4. Thirumalaisamy P. Velavan , Christian G. Meyer. The COVID-19 epidemic. Trop Med Int Health 2020; 25:278-80. doi: 10.1111/tmi.13383
5. Ijaz MK, Brunner AH, Sattar SA, Nair RC, Johnson-Lussenburg CM. Survival characteristics of airborne human coronavirus 229E. J Gen Virol 1985; 66:2743-8.
6. Munster V J, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China- Key Questions for Impact Assessment. New Eng J Med 2020; 382:692-4.
7. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical cou-rse and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054-62.
doi: 10.1016/S0140-6736(20)30566-3
8. Cai J, Sun W, Huang J, Gamber M, Wu J, He G. Indirect virus transmission in cluster of covid-19 cases, Wenzhou, China. Emerg Infect Dis 2020; 26:1343-5.
doi: 10.3201/eid2606.200412
9. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presu-med Asymptomatic Carrier Transmission of COVID-19. J Am Med Assoc 2020; 323:1406-7.
doi: 10.1001/jama.2020.2565
10. Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM, et al. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med 2020; 9:538. doi: 10.3390/jcm9020538
11. Mattiuzzi C, Lippi G. Which lessons shall we learn from the 2019 novel coronavirus outbreak? Ann Transl Med 2020; 8:48.
doi: 10.21037/atm.2020.02.06
12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395:507-13.
doi: 10.1016/S0140-6736(20)30211-7
13. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395:470-3.
doi: 10.1016/S0140-6736(20)30185-9
14. Wang T, Du Z, Zhu F, Cao Z, An Y, Jiang B, et al. Comor bidities and multi-organ injuries in the treatment of COVID-19. Lancet 2020; 395:52.
doi: 10.1016/S0140-6736(20)30558-4
15. Xie J, Tong Z, Guan X, Du B, Qiu H. Clinical Characterist-ics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Netw Open. 2020;3(4):e205619.
doi:10.1001/jamanetworkopen.2020.5619
16. Chang D, Lin M, Wei L, Xie L, Zhu G, Cruz CS, et al. Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China. JAMA 2020; 323:1092-3.
doi:10.1001/jama.2020.1623
17. Wenham C, Smith J, Morgan R.COVID-19: the gendered impacts of the outbreak. Lancet 2020; 395:846-8. doi: 10.1016/S0140-6736(20)30526-2
18. Feng Z, Li Q, Zhang Y. The Epidemiological charac-teristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. China CDC Weekly 2020; 2:113-22.
19. How to Protect Yourself & Others. https://www.cdc. gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. (Accessed 27 April 2020)
20. Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. (Accessed 27 April 2020)
21. Lorenzo Villalba N, Maouche Y, Alonso Ortiz MB. Anosmia and dysgeusia in the absence of other respiratory diseases: should covid-19 infection be considered? Eur J Case Rep Intern Med 2020; 7:001641. doi: 10.12890/2020_001641
22. JiangX, Rayner S, Luo H. Does SARS‐CoV‐2 has a longer incubation period than SARS and MERS? J Med Virol 2020; 92:476-8. doi: 10.1002/jmv.25708
23. Asadi S, Bouvier N, Anthony S. Ristenpart W. The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? Aerosol Sci Technol 2020; 54:635-8. doi: 10.1080/02786826.2020.1749229
24. Guan WJ, Liang Wh, Zhao Y. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J 2020; 55: 2000547.
doi: 10.1183/13993003.00547-2020
25. Boosting Immunity: Functional Medicine Tips on Prevention & Optimizing Immune Function During the COVID-19 (Coronavirus) Outbreak. https://www. ifm.org/news-insights/boosting-immunity-functional-medicine-tips-prevention-immunity-boosting-covid-19-coronavirus-outbreak/. (Accessed on 27 April 2020)
26. CORONAVIRUS: Can you get covid-19 twice or does it cause immunity? https://www.independent.co.uk/life-style/health-and-families/coronavirus-immunity-reinfection-get-covid-19-twice-sick-spread-relapse-a9400691.html (Accessed on 27 April 2020)
27. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020;8:e21.
doi:10.1016/S2213-2600(20)30116-8.
28. Zhang J Zeng H, Gu J , Li H, Zheng L, Zou Q. Progress and prospects on vaccine development against SARS-CoV-2. Vaccines (Basel) 2020; 8:153.
doi: 10.3390/vaccines8020153
29. Sandaradura I, Goeman E, Pontivivo G, Fine E, Gray H, Kerr S, et al. A close shave? Performance of P2/N95 respirators in healthcare workers with facial hair: results of the BEARDS (BEnchmarking Adequate Respiratory DefenceS) study. J Hosp Infect 2020; 104:529-33.
doi:10.1016/j.jhin.2020.01.006
30. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19). https://apps.-who.int/iris/bitstream/handle/10665/331215/WHO-2019-nCov-IPCPPE_use-2020.1-eng.pdf (Accessed April 18, 2020)
31. Everything you need to know about washing your hands to protect against coronavirus (COVID-19). https://www.unicef.org/rosa/stories/everything-you-need-know-about-washing-your-hands-protect-against-coronavirus-covid-19. (Accessed 27 April 2020) 32. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Preval-ence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; 109:531-8.
doi:10.1007/s00392-020-01626-9
33. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109:102433.
doi:10.1016/j.jaut.2020.102433
34. Information for Healthcare Professionals about Coronavirus (COVID-19). https://www.-cdc.gov/coronavirus/2019-ncov/hcp/index.html. (Accessed on 27 April 2020)
35. Ahmed N, Shakoor M, Vohra F, Abduljabbar T, Mariam Q, Rehman MA. Knowledge, Awareness and Practice of Health care Professionals amid SARS-CoV-2, Corona Virus Disease Outbreak. Pak J Med Sci 2020; 36:S49-56.
doi:10.12669/pjms.36.COVID19-S4.2704
36. Sarfaraz S, Shabbir J, Mudasser MA, Khurshid Z, Al-Quraini AA, Abbasi MS, et al. Knowledge and Attitude of Dental Practitioners Related to Disinfection during the COVID-19 Pandemic. Healthcare (Basel) 2020; 8:E232. doi:10.3390/healthcare8030232
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Abhishek Lal, Mahnoor Khawaja M. Saleem, Anas Sanaullah, Mahnoor Sheikh, Sara Saaed, Naseer Ahmed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. 
